198 related articles for article (PubMed ID: 10501847)
1. Tumor-induced immune dysfunction.
Kiessling R; Wasserman K; Horiguchi S; Kono K; Sjöberg J; Pisa P; Petersson M
Cancer Immunol Immunother; 1999 Oct; 48(7):353-62. PubMed ID: 10501847
[TBL] [Abstract][Full Text] [Related]
2. MHC gene control of the natural killer system at the level of the target and the host.
Kärre K
Semin Cancer Biol; 1991 Oct; 2(5):295-309. PubMed ID: 1773046
[TBL] [Abstract][Full Text] [Related]
3. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.
Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R
Cancer Res; 1999 Jun; 59(12):2950-6. PubMed ID: 10383160
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor immunity and cellular cancer therapies].
Catros-Quemener V; Bouet F; Genetet N
Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
[TBL] [Abstract][Full Text] [Related]
5. Cellular mechanisms of lymphocyte-mediated lysis of tumor cells.
Arancia G; Malorni W; Donelli G
Ann Ist Super Sanita; 1990; 26(3-4):369-84. PubMed ID: 2151107
[TBL] [Abstract][Full Text] [Related]
6. CD8
Uzhachenko RV; Shanker A
Front Immunol; 2019; 10():1906. PubMed ID: 31456803
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of human cytotoxic T lymphocytes against autologous tumor by a factor released from human monocytic leukemia cell line.
Maeda N; Hamasato S; Miyazawa H; Takata M; Yamamoto H; Fujimoto S
Jpn J Cancer Res; 1989 Jun; 80(6):537-45. PubMed ID: 2503475
[TBL] [Abstract][Full Text] [Related]
8. Immune response to ultraviolet-induced tumors. III. Analysis of cloned lymphocyte populations exhibiting antitumor activity.
Streeter PR; Fortner GW
Transplantation; 1988 Aug; 46(2):256-60. PubMed ID: 3261463
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cell-tumor coculturing vaccine can induce antitumor immunity through both NK and CTL interaction.
Kim KD; Choi SC; Kim A; Choe YK; Choe IS; Lim JS
Int Immunopharmacol; 2001 Nov; 1(12):2117-29. PubMed ID: 11710541
[TBL] [Abstract][Full Text] [Related]
10. Signaling through NK cell-associated CD137 promotes both helper function for CD8+ cytolytic T cells and responsiveness to IL-2 but not cytolytic activity.
Wilcox RA; Tamada K; Strome SE; Chen L
J Immunol; 2002 Oct; 169(8):4230-6. PubMed ID: 12370353
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of organophosphorus pesticide-induced inhibition of cytolytic activity of killer cells.
Li Q; Kawada T
Cell Mol Immunol; 2006 Jun; 3(3):171-8. PubMed ID: 16893497
[TBL] [Abstract][Full Text] [Related]
12. Re-targeting of cytotoxic T lymphocytes and/or natural killer cells to CEA-expressing tumor cells with anti-CEA antibody activity.
Kuroki M; Hachimine K; Huang J; Shibaguchi H; Kinugasa T; Maekawa S; Kuroki M
Anticancer Res; 2005; 25(6A):3725-32. PubMed ID: 16302732
[TBL] [Abstract][Full Text] [Related]
13. Correlation of murine susceptibility to tumor, parasite and bacterial challenge with altered cell-mediated immunity following systemic exposure to the tumor promoter phorbol myristate acetate.
Murray MJ; Lauer LD; Luster MI; Luebke RW; Adams DO; Dean JH
Int J Immunopharmacol; 1985; 7(4):491-500. PubMed ID: 3876295
[TBL] [Abstract][Full Text] [Related]
14. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of cellular immune response by Ipomoea obscura and Ipobscurine alkaloid attenuates tumor growth in mice.
Hamsa TP; Kuttan G
Can J Physiol Pharmacol; 2011 Apr; 89(4):259-68. PubMed ID: 21539469
[TBL] [Abstract][Full Text] [Related]
16. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
Pievani A; Borleri G; Pende D; Moretta L; Rambaldi A; Golay J; Introna M
Blood; 2011 Sep; 118(12):3301-10. PubMed ID: 21821703
[TBL] [Abstract][Full Text] [Related]
17. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
[TBL] [Abstract][Full Text] [Related]
18. A novel target cell antigen involved in the NK-like lytic activity of antigen-specific cytotoxic T lymphocytes.
Harris DT; Jaso-Friedmann L; Evans DL
Immunol Lett; 1993 Sep; 38(1):11-8. PubMed ID: 8300148
[TBL] [Abstract][Full Text] [Related]
19. Stress-induced suppression of herpes simplex virus (HSV)-specific cytotoxic T lymphocyte and natural killer cell activity and enhancement of acute pathogenesis following local HSV infection.
Bonneau RH; Sheridan JF; Feng NG; Glaser R
Brain Behav Immun; 1991 Jun; 5(2):170-92. PubMed ID: 1654165
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of MICA and MICB Shedding Elicits NK-Cell-Mediated Immunity against Tumors Resistant to Cytotoxic T Cells.
Ferrari de Andrade L; Kumar S; Luoma AM; Ito Y; Alves da Silva PH; Pan D; Pyrdol JW; Yoon CH; Wucherpfennig KW
Cancer Immunol Res; 2020 Jun; 8(6):769-780. PubMed ID: 32209637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
